Active	Status	Sponsor type	Region	Phase	Filter
8 Active 0 Inactive 8 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

8 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Leuzzi, Giacomo
INF-DM2-Ther, NCT04392557: Anti-inflammatory Status in DM2 Treated Patients	Recruiting	4	36	Europe	Metformin / alogliptin Oral Product, Metformin / Pioglitazone Pill, triple therapy	University of Catanzaro	Diabetes Mellitus, Type 2	09/20	06/21
NCT04567212: Gender Differences and SNPs in Asthmatic Patients	Recruiting	N/A	50	Europe	genetic evaluation, MicroRNA evaluation	University of Catanzaro, Azienda Sanitaria Provinciale Di Catanzaro, Azienda Ospedaliera Policlinico "Mater Domini"	Allergic Asthma, Asthma	11/21	12/21
Scuteri, Antonio
INF-DM2-Ther, NCT04392557: Anti-inflammatory Status in DM2 Treated Patients	Recruiting	4	36	Europe	Metformin / alogliptin Oral Product, Metformin / Pioglitazone Pill, triple therapy	University of Catanzaro	Diabetes Mellitus, Type 2	09/20	06/21
NCT04567212: Gender Differences and SNPs in Asthmatic Patients	Recruiting	N/A	50	Europe	genetic evaluation, MicroRNA evaluation	University of Catanzaro, Azienda Sanitaria Provinciale Di Catanzaro, Azienda Ospedaliera Policlinico "Mater Domini"	Allergic Asthma, Asthma	11/21	12/21
Giuliano, Giuseppe
INF-DM2-Ther, NCT04392557: Anti-inflammatory Status in DM2 Treated Patients	Recruiting	4	36	Europe	Metformin / alogliptin Oral Product, Metformin / Pioglitazone Pill, triple therapy	University of Catanzaro	Diabetes Mellitus, Type 2	09/20	06/21
NCT04567212: Gender Differences and SNPs in Asthmatic Patients	Recruiting	N/A	50	Europe	genetic evaluation, MicroRNA evaluation	University of Catanzaro, Azienda Sanitaria Provinciale Di Catanzaro, Azienda Ospedaliera Policlinico "Mater Domini"	Allergic Asthma, Asthma	11/21	12/21
Guerra, Antonio
INF-DM2-Ther, NCT04392557: Anti-inflammatory Status in DM2 Treated Patients	Recruiting	4	36	Europe	Metformin / alogliptin Oral Product, Metformin / Pioglitazone Pill, triple therapy	University of Catanzaro	Diabetes Mellitus, Type 2	09/20	06/21
NCT04567212: Gender Differences and SNPs in Asthmatic Patients	Recruiting	N/A	50	Europe	genetic evaluation, MicroRNA evaluation	University of Catanzaro, Azienda Sanitaria Provinciale Di Catanzaro, Azienda Ospedaliera Policlinico "Mater Domini"	Allergic Asthma, Asthma	11/21	12/21

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Leuzzi, Giacomo
INF-DM2-Ther, NCT04392557: Anti-inflammatory Status in DM2 Treated Patients	Recruiting	4	36	Europe	Metformin / alogliptin Oral Product, Metformin / Pioglitazone Pill, triple therapy	University of Catanzaro	Diabetes Mellitus, Type 2	09/20	06/21
NCT04567212: Gender Differences and SNPs in Asthmatic Patients	Recruiting	N/A	50	Europe	genetic evaluation, MicroRNA evaluation	University of Catanzaro, Azienda Sanitaria Provinciale Di Catanzaro, Azienda Ospedaliera Policlinico "Mater Domini"	Allergic Asthma, Asthma	11/21	12/21
Scuteri, Antonio
INF-DM2-Ther, NCT04392557: Anti-inflammatory Status in DM2 Treated Patients	Recruiting	4	36	Europe	Metformin / alogliptin Oral Product, Metformin / Pioglitazone Pill, triple therapy	University of Catanzaro	Diabetes Mellitus, Type 2	09/20	06/21
NCT04567212: Gender Differences and SNPs in Asthmatic Patients	Recruiting	N/A	50	Europe	genetic evaluation, MicroRNA evaluation	University of Catanzaro, Azienda Sanitaria Provinciale Di Catanzaro, Azienda Ospedaliera Policlinico "Mater Domini"	Allergic Asthma, Asthma	11/21	12/21
Giuliano, Giuseppe
INF-DM2-Ther, NCT04392557: Anti-inflammatory Status in DM2 Treated Patients	Recruiting	4	36	Europe	Metformin / alogliptin Oral Product, Metformin / Pioglitazone Pill, triple therapy	University of Catanzaro	Diabetes Mellitus, Type 2	09/20	06/21
NCT04567212: Gender Differences and SNPs in Asthmatic Patients	Recruiting	N/A	50	Europe	genetic evaluation, MicroRNA evaluation	University of Catanzaro, Azienda Sanitaria Provinciale Di Catanzaro, Azienda Ospedaliera Policlinico "Mater Domini"	Allergic Asthma, Asthma	11/21	12/21
Guerra, Antonio
INF-DM2-Ther, NCT04392557: Anti-inflammatory Status in DM2 Treated Patients	Recruiting	4	36	Europe	Metformin / alogliptin Oral Product, Metformin / Pioglitazone Pill, triple therapy	University of Catanzaro	Diabetes Mellitus, Type 2	09/20	06/21
NCT04567212: Gender Differences and SNPs in Asthmatic Patients	Recruiting	N/A	50	Europe	genetic evaluation, MicroRNA evaluation	University of Catanzaro, Azienda Sanitaria Provinciale Di Catanzaro, Azienda Ospedaliera Policlinico "Mater Domini"	Allergic Asthma, Asthma	11/21	12/21